Učitavanje...
Pancreatic cancer: current standards, working towards a new therapeutic approach
Pancreatic cancer is the fourth leading cause of cancer deaths with a 5-year survival of 4–6%. Clinical challenges remain to be addressed, since few promising approaches to treat pancreatic cancer have been reported. Here we discuss the potential of a new biotherapeutic agent composed of a lysosomal...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4086873/ https://ncbi.nlm.nih.gov/pubmed/24621210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.895937 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|